[{"NetIncomeLoss_1_Q1_USD":-172947000.0,"MarketableSecuritiesCurrent_0_Q1_USD":140014000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q1_USD":0.0,"InventoryGross_0_Q1_USD":103678000.0,"DepreciationAndAmortization_1_Q1_USD":849000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":72832953.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":44840000.0,"InventoryFinishedGoods_0_Q1_USD":38307000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-307000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":440000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-285475000.0,"PurchaseObligation_0_Q1_USD":60503000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1730000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2889000.0,"AssetsCurrent_0_Q1_USD":617261000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":39391000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":869000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":7511000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":360000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":37997305.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4429000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3438000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":100000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":530000.0,"CommonStockSharesIssued_0_Q1_shares":73122908.0,"Assets_0_Q1_USD":693303000.0,"ShareBasedCompensation_1_Q1_USD":16884000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":9430000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":-16663000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-37000.0,"LongTermLoansPayable_0_Q1_USD":74696000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2572000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":203492000.0,"GainLossOnContractTermination_1_Q1_USD":-3210000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":12892000.0,"InventoryRawMaterials_0_Q1_USD":3727000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-2109000.0,"EarningsPerShareBasic_1_Q1_USD":-2.37,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":72832953.0,"PurchaseObligationDueInSecondYear_0_Q1_USD":9753000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":61000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"PurchaseObligationDueInNextTwelveMonths_0_Q1_USD":15946000.0,"CommonStockValue_0_Q1_USD":7000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2439000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q1_USD":26949000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"CostsAndExpenses_1_Q1_USD":250394000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":1606000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_1_Q1_USD":0.0,"ConvertibleNotesPayableCurrent_0_Q1_USD":80240000.0,"IncreaseDecreaseInInventories_1_Q1_USD":11378000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":700000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q1_USD":17279000.0,"OtherAssetsNoncurrent_0_Q1_USD":10744000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":259489000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":8375000.0,"Liabilities_0_Q1_USD":565632000.0,"FinanceLeaseLiability_0_Q1_USD":1506000.0,"OperatingLeaseLiability_0_Q1_USD":11026000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-172984000.0,"InterestExpenseRelatedParty_1_Q1_USD":631000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"Goodwill_0_Q1_USD":943000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-172947000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1730000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16982000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-37000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1367000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":72832953.0,"InventoryWorkInProcess_0_Q1_USD":61644000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3293000.0,"LiabilitiesCurrent_0_Q1_USD":257601000.0,"AccountsPayableCurrent_0_Q1_USD":15482000.0,"InterestExpense_1_Q1_USD":5648000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":259929000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10350000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4329000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":10944000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":16000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2620000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.081,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q1_security":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":72832953.0,"AdditionalPaidInCapital_0_Q1_USD":1063672000.0,"OperatingLeasePayments_1_Q1_USD":900000.0,"ConvertibleSubordinatedDebtNoncurrent_0_Q1_USD":223341000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"InventoryNoncurrent_0_Q1_USD":52065000.0,"ReceivablesNetCurrent_0_Q1_USD":140410000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-160000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.058,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":140330000.0,"EarningsPerShareDiluted_1_Q1_USD":-2.37,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q1_USD":9670000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1866000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":4621000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":203000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"OperatingIncomeLoss_1_Q1_USD":-167360000.0,"InventoryNet_0_Q1_USD":51613000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":693303000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":12090000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":1508000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":1001000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2651000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":212000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":16897000.0,"ProfitLoss_1_Q1_USD":-172947000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":750000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":637000.0,"StockholdersEquity_0_Q1_USD":127671000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":34204000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":145000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-279000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":83034000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-935701000.0,"LeaseCost_1_Q1_USD":800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-281669000.0,"CommonStockSharesOutstanding_0_Q1_shares":73122908.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"PurchaseObligationDueInThirdYear_0_Q1_USD":600000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]